{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:30:20Z","timestamp":1772166620355,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychol"],"DOI":"10.1186\/s40359-025-03921-4","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:53:54Z","timestamp":1768985634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mindset over molecule: comparing self-transcendent and mystical experiences across recreational psilocybin, MDMA, and cannabis use"],"prefix":"10.1186","volume":"14","author":[{"given":"Christina","family":"Chwyl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Spata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason B.","family":"Luoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"11","key":"3921_CR1","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","volume":"235","author":"AL Danforth","year":"2018","unstructured":"Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, et al. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology. 2018;235(11):3137\u201348.","journal-title":"Psychopharmacology"},{"issue":"16","key":"3921_CR2","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1017\/S003329172000389X","volume":"50","author":"SB Goldberg","year":"2020","unstructured":"Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, et al. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis. Psychol Med. 2020;50(16):2655\u201366.","journal-title":"Psychol Med"},{"issue":"3","key":"3921_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1176\/appi.focus.23021011","volume":"21","author":"JM Mitchell","year":"2023","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Focus. 2023;21(3):315\u201328.","journal-title":"Focus"},{"issue":"4","key":"3921_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcph.1995","volume":"62","author":"KW Smith","year":"2022","unstructured":"Smith KW, Sicignano DJ, Hernandez AV, White CM. MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: a systematic review with meta\u2010analysis. J Clin Pharma. 2022;62(4):463\u201371.","journal-title":"J Clin Pharma"},{"key":"3921_CR5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-017-4769-4","volume":"235","author":"TM Carbonaro","year":"2018","unstructured":"Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology. 2018;235:521\u201334.","journal-title":"Psychopharmacology"},{"issue":"8","key":"3921_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2013.12.015","volume":"78","author":"RL Carhart-Harris","year":"2015","unstructured":"Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, et al. The effects of acutely administered 3, 4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level\u2013dependent resting state functional connectivity. Biol Psychiatry. 2015;78(8):554\u201362.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"3921_CR7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/0269881118769063","volume":"32","author":"AK Davis","year":"2018","unstructured":"Davis AK, Barsuglia JP, Lancelotta R, Grant RM, Renn E. The epidemiology of 5-methoxy- N, N -dimethyltryptamine (5-MeO-DMT) use: benefits, consequences, patterns of use, subjective effects, and reasons for consumption. J Psychopharmacol. 2018;32(7):779\u201392.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"3921_CR8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-017-4650-5","volume":"235","author":"PC Dolder","year":"2018","unstructured":"Dolder PC, M\u00fcller F, Schmid Y, Borgwardt SJ, Liechti ME. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects. Psychopharmacology. 2018;235(2):467\u201379.","journal-title":"Psychopharmacology"},{"key":"3921_CR9","doi-asserted-by":"crossref","unstructured":"Goldy SP, Du BA, Rohde JS, Nayak SM, Strickland JC, Ehrenkranz R,\u00a0et al. Psychedelic risks and benefits: A cross-sectional survey study. Journal of Psychopharmacology. 2025;39(5):436-52.","DOI":"10.1177\/02698811241292951"},{"issue":"3","key":"3921_CR10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","volume":"45","author":"F Holze","year":"2020","unstructured":"Holze F, Vizeli P, M\u00fcller F, Ley L, Duerig R, Varghese N, et al. Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology. 2020;45(3):462\u201371.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"3921_CR11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","volume":"47","author":"F Holze","year":"2022","unstructured":"Holze F, Ley L, M\u00fcller F, Becker AM, Straumann I, Vizeli P, et al. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology. 2022;47(6):1180\u20137.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"3921_CR12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/02791072.2012.736842","volume":"44","author":"M Lyvers","year":"2012","unstructured":"Lyvers M, Meester M. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. J Psychoact Drugs. 2012;44(5):410\u20137.","journal-title":"J Psychoact Drugs"},{"key":"3921_CR13","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1199642","volume":"14","author":"SM Nayak","year":"2023","unstructured":"Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, et al. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Front Psychiatry. 2023;14:1199642.","journal-title":"Front Psychiatry"},{"key":"3921_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104793","author":"M van Elk","year":"2022","unstructured":"van Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review. Neurosci Biobehav Rev. 2022. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104793.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"3921_CR15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","volume":"4","author":"DB Yaden","year":"2021","unstructured":"Yaden DB, Griffiths RR. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol Transl Sci. 2021;4(2):568\u201372.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"3921_CR16","volume":"11","author":"MK Doss","year":"2021","unstructured":"Doss MK, Pova\u017ean M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry. 2021;11(1):574.","journal-title":"Transl Psychiatry"},{"key":"3921_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neubiorev.2020.03.017","volume":"113","author":"JS Aday","year":"2020","unstructured":"Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK. Long-term effects of psychedelic drugs: a systematic review. Neurosci Biobehav Rev. 2020;113:179\u201389.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"3921_CR18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/1468794114550679","volume":"15","author":"A Garcia-Romeu","year":"2015","unstructured":"Garcia-Romeu A, Himelstein SP, Kaminker J. Self-transcendent experience: a grounded theory study. Qual Res. 2015;15(5):633\u201354.","journal-title":"Qual Res"},{"key":"3921_CR19","unstructured":"Yaden DB The Measurement and Experimental Manipulation of Self-Transcendent Experience [PhD Thesis]. University of Pennsylvania; 2020. Available from. https:\/\/repository.upenn.edu\/entities\/publication\/85984323-0342-4a98-a434-038a1dbab262. [cited 2025 Apr 14]."},{"issue":"2","key":"3921_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1037\/gpr0000102","volume":"21","author":"DB Yaden","year":"2017","unstructured":"Yaden DB, Haidt J, Hood RW, Vago DR, Newberg AB. The varieties of self-transcendent experience. Rev Gen Psychol. 2017;21(2):143\u201360.","journal-title":"Rev Gen Psychol"},{"issue":"3","key":"3921_CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/02791072.2022.2079108","volume":"55","author":"AA De Deus Pontual","year":"2023","unstructured":"De Deus Pontual AA, Senhorini HG, Corradi-Webster CM, T\u00f3foli LF, Daldegan-Bueno D. Systematic review of psychometric instruments used in research with psychedelics. J Psychoactive Drugs. 2023;55(3):359\u201368.","journal-title":"J Psychoactive Drugs"},{"issue":"11","key":"3921_CR22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","volume":"29","author":"FS Barrett","year":"2015","unstructured":"Barrett FS, Johnson MW, Griffiths RR. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. J Psychopharmacol. 2015;29(11):1182\u201390.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"3921_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0269881120959604","volume":"35","author":"Y Schmid","year":"2021","unstructured":"Schmid Y, Gasser P, Oehen P, Liechti ME. Acute subjective effects in LSD- and MDMA-assisted psychotherapy. J Psychopharmacol. 2021;35(4):362\u201374.","journal-title":"J Psychopharmacol"},{"key":"3921_CR24","doi-asserted-by":"crossref","unstructured":"Fitzgerald P, Webb SL, Denning N, Dowie T, Schweickle M, Modak A et al. Understanding the Psychological Effects of Psilocybin and 3, 4-Methylenedioxymethamphetamine in a Non-Clinical Population. medRxiv. 2025;2025\u201305.","DOI":"10.1101\/2025.05.28.25328532"},{"issue":"8","key":"3921_CR25","doi-asserted-by":"crossref","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","volume":"5","author":"E Studerus","year":"2010","unstructured":"Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One. 2010;5(8):e12412.","journal-title":"PLoS One"},{"issue":"1","key":"3921_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1037\/tra0001108","volume":"14","author":"PP Grau","year":"2022","unstructured":"Grau PP, Kusch MM, Williams MT, Loyo KT, Zhang X, Warner RC, et al. A review of the inclusion of ethnoracial groups in empirically supported posttraumatic stress disorder treatment research. Psychol Trauma Theory Res Pract Policy. 2022;14(1):55\u201365.","journal-title":"Psychol Trauma Theory Res Pract Policy"},{"key":"3921_CR27","doi-asserted-by":"crossref","first-page":"100967","DOI":"10.1016\/j.newideapsych.2022.100967","volume":"67","author":"G Ona","year":"2022","unstructured":"Ona G, Kohek M, Bouso JC. The illusion of knowledge in the emerging field of psychedelic research. New Ideas Psychol. 2022;67:100967.","journal-title":"New Ideas Psychol"},{"key":"3921_CR28","doi-asserted-by":"crossref","unstructured":"Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R. Survey of subjective \u201cGod encounter experiences\u201d: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Frey R, editor. PLoS ONE. 2019;14(4):e0214377.","DOI":"10.1371\/journal.pone.0214377"},{"issue":"1","key":"3921_CR29","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1038\/s41598-023-40856-5","volume":"13","author":"RJ Zeifman","year":"2023","unstructured":"Zeifman RJ, Kettner H, Pagni BA, Mallard A, Roberts DE, Erritzoe D, et al. Co-use of MDMA with psilocybin\/LSD May buffer against challenging experiences and enhance positive experiences. Sci Rep. 2023;13(1):13645.","journal-title":"Sci Rep"},{"issue":"2","key":"3921_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1176\/ajp.128.2.213","volume":"128","author":"MH Keeler","year":"1971","unstructured":"Keeler MH, Ewing JA, Rouse BA. Hallucinogenic effects of marijuana as currently used. AJP. 1971;128(2):213\u20136.","journal-title":"AJP"},{"issue":"5","key":"3921_CR31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/02791072.2019.1645371","volume":"51","author":"S Farmer","year":"2019","unstructured":"Farmer S, Slavin MN, Loflin MJE, Luba R, Earleywine M. Aversiveness and meaningfulness of uncomfortable experiences with edible cannabis. J Psychoactive Drugs. 2019;51(5):413\u201320.","journal-title":"J Psychoactive Drugs"},{"issue":"7","key":"3921_CR32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/0269881121997099","volume":"35","author":"M Earleywine","year":"2021","unstructured":"Earleywine M, Ueno LF, Mian MN, Altman BR. Cannabis-induced oceanic boundlessness. J Psychopharmacol. 2021;35(7):841\u20137.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"3921_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G* power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391.","journal-title":"Behav Res Methods"},{"issue":"2","key":"3921_CR34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/acsptsci.1c00014","volume":"4","author":"JS Aday","year":"2021","unstructured":"Aday JS, Davis AK, Mitzkovitz CM, Bloesch EK, Davoli CC. Predicting reactions to psychedelic drugs: a systematic review of States and traits related to acute drug effects. ACS Pharmacol Transl Sci. 2021;4(2):424\u201335.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"3921_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/cns0000169","volume":"6","author":"SL Russ","year":"2019","unstructured":"Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS. States and traits related to the quality and consequences of psychedelic experiences. Psychol Consciousness Theory Res Pract. 2019;6(1):1\u201321.","journal-title":"Psychol Consciousness Theory Res Pract"},{"issue":"3","key":"3921_CR36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(00)00175-7","volume":"62","author":"J Riba","year":"2001","unstructured":"Riba J, Rodr\u0131\u0301guez-Fornells A, Strassman RJ, Barbanoj MJ. Psychometric assessment of the hallucinogen rating scale\u2606. Drug Alcohol Depend. 2001;62(3):215\u201323.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"3921_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R. Dose-response study of N,N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry. 1994;51(2):98\u2013108.","journal-title":"Arch Gen Psychiatry"},{"key":"3921_CR38","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00213-019-05279-z","volume":"236","author":"SL Russ","year":"2019","unstructured":"Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS. Replication and extension of a model predicting response to psilocybin. Psychopharmacology. 2019;236:3221\u201330.","journal-title":"Psychopharmacology"},{"key":"3921_CR39","unstructured":"Rockhill K Insights from NSIHT Pilot: National Survey Investigating Hallucinogenic Trend. 18th Annual Scientific Meeting. Rocky Mountain Poison & Drug Safety (RMPDS); 2024. Available from. https:\/\/www.radars.org\/annual-meetings-a.html."},{"issue":"2","key":"3921_CR40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1037\/0022-3514.84.2.365","volume":"84","author":"BL Fredrickson","year":"2003","unstructured":"Fredrickson BL, Tugade MM, Waugh CE, Larkin GR. What good are positive emotions in crisis? A prospective study of resilience and emotions following the terrorist attacks on the united States on September 11th, 2001. J Pers Soc Psychol. 2003;84(2):365.","journal-title":"J Pers Soc Psychol"},{"issue":"4","key":"3921_CR41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-5906.2012.01685.x","volume":"51","author":"KA MacLean","year":"2012","unstructured":"MacLean KA, Leoutsakos JMS, Johnson MW, Griffiths RR. Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin. Sci Study Relig. 2012;51(4):721\u201337.","journal-title":"Sci Study Relig"},{"issue":"1","key":"3921_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","volume":"32","author":"RR Griffiths","year":"2018","unstructured":"Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol. 2018;32(1):49\u201369.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"3921_CR43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0022022106297301","volume":"38","author":"ER Thompson","year":"2007","unstructured":"Thompson ER. Development and validation of an internationally reliable Short-Form of the positive and negative affect schedule (PANAS). J Cross-Cult Psychol. 2007;38(2):227\u201342.","journal-title":"J Cross-Cult Psychol"},{"key":"3921_CR44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2018.00897","volume":"9","author":"ECHM Haijen","year":"2018","unstructured":"Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, et al. Predicting responses to psychedelics: A prospective study. Front Pharmacol. 2018;9:897.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3921_CR45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0092-6566(03)00046-1","volume":"37","author":"SD Gosling","year":"2003","unstructured":"Gosling SD, Rentfrow PJ, Swann WB. A very brief measure of the Big-Five personality domains. J Res Pers. 2003;37(6):504\u201328.","journal-title":"J Res Pers"},{"key":"3921_CR46","doi-asserted-by":"crossref","first-page":"1202953","DOI":"10.3389\/fpsyg.2023.1202953","volume":"14","author":"MM Th\u00f8rrisen","year":"2023","unstructured":"Th\u00f8rrisen MM, Sadeghi T. The Ten-Item personality inventory (TIPI): a scoping review of versions, translations and psychometric properties. Front Psychol. 2023;14:1202953.","journal-title":"Front Psychol"},{"issue":"2","key":"3921_CR47","first-page":"119","volume":"33","author":"GA Jamieson","year":"2005","unstructured":"Jamieson GA. The modified Tellegen absorption scale: a clearer window on the structure and meaning of absorption. Aust J Clin Exp Hypn. 2005;33(2):119.","journal-title":"Aust J Clin Exp Hypn"},{"key":"3921_CR48","first-page":"1","volume":"45","author":"S Van Buuren","year":"2011","unstructured":"Van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"key":"3921_CR49","unstructured":"Kassambara A. rstatix: Pipe-Friendly Framework for Basic Statistical Tests. 2023. Available from: https:\/\/CRAN.R-project.org\/package=rstatix."},{"key":"3921_CR50","unstructured":"Smyth G, Smyth MG The statmod package. Citeseer; 2007. Available from.\u00a0https:\/\/citeseerx.ist.psu.edu\/document?repid=rep1&type=pdf&doi=ecd3c9de85c820ad6b8e9252e8e7587773b01517.\u00a0[cited 2024 Nov 20]."},{"key":"3921_CR51","unstructured":"Lenth RV, Banfai B, Bolker B, Buerkner P, Gin\u00e9-V\u00e1zquez I, Herve M et al emmeans: Estimated Marginal Means, aka Least-Squares Means. 2025. Available from. https:\/\/cran.r-project.org\/web\/packages\/emmeans\/index.html. [cited 2025 Apr 16]."},{"issue":"7754","key":"3921_CR52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1075-9","volume":"569","author":"R Nardou","year":"2019","unstructured":"Nardou R, Lewis EM, Rothhaas R, Xu R, Yang A, Boyden E, et al. Oxytocin-dependent reopening of a social reward learning critical period with MDMA. Nature. 2019;569(7754):116\u201320.","journal-title":"Nature"},{"issue":"5","key":"3921_CR53","first-page":"490","volume":"9","author":"Y Schmid","year":"2024","unstructured":"Schmid Y, Bershad AK. Altered states and social bonds: effects of MDMA and serotonergic psychedelics on social behavior as a mechanism underlying substance-assisted therapy. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9(5):490\u20139.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"6","key":"3921_CR54","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/dar.13480","volume":"41","author":"LA Basedow","year":"2022","unstructured":"Basedow LA, Kuitunen-Paul S. Motives for the use of serotonergic psychedelics: a systematic review. Drug Alcohol Rev. 2022;41(6):1391\u2013403.","journal-title":"Drug Alcohol Rev"},{"key":"3921_CR55","unstructured":"Schultes RE, Hofmann A Plants of the gods: their sacred, healing, and hallucinogenic powers. 1992. Available from:. https:\/\/agris.fao.org\/search\/en\/providers\/123819\/records\/64735d8308fd68d546030f63. [cited 2025 Jun 11]."},{"key":"3921_CR56","unstructured":"Sanabria E, T\u00f3foli LF Integration or commodification? A critical review of individual-centered approaches in psychedelic healing. J Psychedelic Stud. 2025. Available from:. https:\/\/akjournals.com\/view\/journals\/2054\/aop\/article-10.1556-2054.2024.00411\/article-10.1556-2054.2024.00411.xml. [cited 2025 Jun 11]."},{"key":"3921_CR57","doi-asserted-by":"crossref","unstructured":"Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Bezo A, et al. The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. 2025;172:106086.","DOI":"10.1016\/j.neubiorev.2025.106086"},{"key":"3921_CR58","unstructured":"U.S. Census Bureau. QuickFacts: United States. 2024. Available from: https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045224. [cited 2025 May 22]."}],"container-title":["BMC Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40359-025-03921-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-025-03921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-025-03921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:06:17Z","timestamp":1771596377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40359-025-03921-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3921"],"URL":"https:\/\/doi.org\/10.1186\/s40359-025-03921-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7266162\/v1","asserted-by":"object"}]},"ISSN":["2050-7283"],"issn-type":[{"value":"2050-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study procedures were approved by the Behavioral Health Research Collective Institutional Review Board (#047) and carried out in accordance with the provisions of the World Medical Association Declaration of Helsinki. Written verbal informed consent was obtained for all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}